Soliris medication POP: 10/1/2016 to 9/30/2017

Ended Awarded

Contract number
VA26217J0325
Awardee
Awarding agency
Obligated
$291,431

Award facts

Contract value 100% obligated
$291,430.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cheshire, CT 06410, USA

Award details come from SAM.gov/FPDS.

About this award

This is a federal contract award to Alexion Pharmaceuticals Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration. The contract is a delivery order under the VA's Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply Schedule 61-IB, with a firm fixed price and a ceiling value of $291,430.80. The contract is for the supply of the drug Soliris, which is used to treat patients with perinatal/infantile- and juvenile-onset hypophosphatasia, a rare genetic disorder. The contract has an ultimate completion date of September 30, 2017. Alexion Pharmaceuticals is a global biopharmaceutical company that provides pharmaceuticals and drugs to federal agencies through the GSA Schedule program. The VA has also awarded Alexion a Blanket Purchase Agreement (BPA) for the drug Strensiq, under the Pharmaceuticals and Drugs GSA Schedule, with a potential value of $4,239,517.80 and a period of performance from September 1, 2022 through August 31, 2024.

Quick answers

Who was awarded contract VA26217J0325?

VA26217J0325 was awarded to Alexion Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 1, 2016.

How much is contract VA26217J0325 worth?

The government has obligated $291,431 on VA26217J0325.

Is contract VA26217J0325 an order under another contract?

Yes. VA26217J0325 is a delivery order under V797D30015, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA26217J0325 competed?

The extent of competition for VA26217J0325 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award